Європейський Союз -
словенська -
EMA (European Medicines Agency)
elzonris
stemline therapeutics b.v. - tagraxofusp - lymphoma - antineoplastična sredstva - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).
Словенія -
словенська -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
phrompo 250 mg filmsko obložene tablete
gefitinib - filmsko obložena tableta - gefitinib 250 mg / 1 tableta - gefitinib
Європейський Союз -
словенська -
EMA (European Medicines Agency)
sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastična sredstva - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
Словенія -
словенська -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
lerkanidipin teva 10 mg filmsko obložene tablete
teva pharma b.v. - lerkanidipin - filmsko obložena tableta - lerkanidipin 9,4 mg / 1 tableta - lerkanidipin
Словенія -
словенська -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
lerkanidipin teva 20 mg filmsko obložene tablete
teva pharma b.v. - lerkanidipin - filmsko obložena tableta - lerkanidipin 18,8 mg / 1 tableta - lerkanidipin
Словенія -
словенська -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
lerkanidipin teva 20 mg filmsko obložene tablete
teva pharma b.v. - lerkanidipin - filmsko obložena tableta - lerkanidipin 18,8 mg / 1 tableta - lerkanidipin
Словенія -
словенська -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
lerkanidipin teva 10 mg filmsko obložene tablete
teva pharma b.v. - lerkanidipin - filmsko obložena tableta - lerkanidipin 9,4 mg / 1 tableta - lerkanidipin
Європейський Союз -
словенська -
EMA (European Medicines Agency)
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastična sredstva - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
Словенія -
словенська -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
nuvaring 0,120 mg/0,015 mg na 24 ur vaginalni dostavni sistem
merck sharp & dohme, d.o.o. - etinilestradiol; etonogestrel - vaginalni dostavni sistem - etinilestradiol 2,7 mg / 1 sistem etonogestrel11,7 mg / 1 sistem; etonogestrel 11,7 mg / 1 sistem - vaginalni obroček s progestogenom in estrogenom
Словенія -
словенська -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
nuvaring 0,120 mg/0,015 mg na 24 ur vaginalni dostavni sistem
merck sharp & dohme, d.o.o. - etinilestradiol; etonogestrel - vaginalni dostavni sistem - etinilestradiol 2,7 mg / 1 sistem etonogestrel11,7 mg / 1 sistem; etonogestrel 11,7 mg / 1 sistem - vaginalni obroček s progestogenom in estrogenom